11.18.2024 - Extended Benefit
Nov 18, 2024•10 min•Ep. 240
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
Check out this week's QuadCast as we highlight the oncologic benefit of extended nodal dissection for prostate cancer, the comparison of Durvalumab and Cetuximab in cisplatin-ineligible H&N cancer patients, the high incidence of psoriasis development on immunotherapy, and more.
Check out the website and subscribe to the newsletter!
Founders & Lead Authors: Laura Dover & Caleb Dulaney
Podcast Host: Sam Marcrom
For the best experience, listen in Metacast app for iOS or Android